Abstract Search

ea0090oc2.4 | Oral Communications 2: Thyroid | ECE2023

TSH suppression increases the risk of sarcopenia and frailty in the long-term follow-up of elderly patients with differentiated thyroid carcinoma

Coskun Meric , Cataltepe Esra , Varan Hacer Dogan , Ceker Eda , Bektas Yasemin , Kuscu Yasemin , Yalcin Mehmet Muhittin , Akturk Mujde , Toruner Fusun Balos , Karakoc Mehmet Ayhan , Altinova Alev Eroglu

Objective: In differentiated thyroid carcinoma (DTC), TSH suppression with levothyroxine (L-T4) is a standard treatment for reducing tumor recurrence after total thyroidectomy. This study aims to evaluate the effect of long-term TSH suppression on the development of sarcopenia and frailty in elderly patients with DTC.Method: Seventy patients aged 60 years and older with stable TSH levels during the last year and under L-T4 due to DTC were included in the...

0 shares

Endocrine Abstracts

TSH suppression increases the risk of sarcopenia and frailty in the long-term follow-up of elderly patients with differentiated thyroid carcinoma

BiosciAbstracts